Posts in tag

biosimilars


The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …

The Generic and Biosimilar Medicines Association has welcomed the approval of biosimilar infliximab, Inflectra. Inflectra is the first biosimilar infliximab to be approved in Australia, providing an alternative, affordable treatment …

The Australian Competition and Consumer Commission has announced that it will not oppose Pfizer Inc’s proposed $US17 billion acquisition of Hospira Inc. “Pfizer and Hospira are also the two largest …

From today, the Generic Medicines Industry Association will be known as the Generic and Biosimilar Medicines Association. After patents expire on brand name medicines, affordable generic and biosimilar medicines deliver …

The Consumers Health Forum has expressed its concerns about the issue of substitution of biological medicines with biosimilars, at a meeting called by the Pharmaceutical Benefits Advisory Committee. CEO of …

Medicines Australia says it is “extremely disappointed” with a last-minute decision by Health Minister Sussan Ley to abandon a Strategic Agreement, which it says casts a shadow over the future …

The Australian Rheumatology Association has expressed concerns about risks to patient safety it says could follow from measures on biosimilars going through the Senate today as part of the wider …

The PBAC has issued a statement intending to reassure the public about the safety of biosimilar copies of biologic drugs, in a bid to stamp out “misinformation” which could slow …

The Generic Medicines Industry Association has welcomed the PBAC’s decision to consider “a” flagging of biosimilars, and to list biosimilar insulin (Basaglar) on the PBS. Basaglar is the first biosimilar …